Pyrimido[4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation

Anti-Cancer Drug Design

Volumn 11, Issue 4, 1996, Pages 339-349

  Antonini, Ippolito ^a   Polucci, Paolo ^a   Cola, Donatella ^a   Bontemps Gracz, Maria ^b   Pescalli, Nicoletta ^c   Menta, Ernesto ^c   Martelli, Sante ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^c Boehringer Mannheim Italia   (Italy)

Author keywords

Anticancer agents; DNA binding agents; Pyrimido 4,5,6 kl acridine

Indexed keywords

ACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; CHLOROFORMIC ACID ETHYL ESTER; HYDROBROMIC ACID;

ANIMAL CELL; ARTICLE; COLON ADENOCARCINOMA; CYTOTOXICITY; DRUG DNA BINDING; DRUG HYDROLYSIS; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL;

ACRIDINES; ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; DNA; HUMANS; LEUKEMIA L1210; MAGNETIC RESONANCE SPECTROSCOPY; MICE; TUMOR CELLS, CULTURED;

EID: 0029899550     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. ANTONINI, I., COLA, D., POLUCCI, P., BONTEMPS-GRACZ, M., BOROWSKI, E. & MARTELLI, S. (1995). Synthesis of (dialkylamino)alkyl-disubstituted pyrimido[5,6,1-de]acridines, a novel group of anticancer agents active on a multidrug resistant cell line. Journal of Medicinal Chemistry, 38, 3282.
2. 3-4-methoxyfumaroyl-L-2,3-diaminopropanoic acid, an antifungal agent, on mammalian cells in tissue culture. Acta Biochimica Polonica, 38, 229.
3. CAPPS, D.B., DUNBAR, J., KESTEN, S.R., SHILLIS, J. & WERBEL, L.M. (1992). 2-Aminoalkyl-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents. Journal of Medicinal Chemistry, 35, 4770.
4. CHEN, Q., DEADY, L.W., BAGULEY, B.C. & DENNY, W.A. (1994). Electron-deficient DNA-intercalating agents as antitumor drugs: aza analogues of the experimental clinical agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. Journal of Medicinal Chemistry, 37, 593.
5. CHOLODY, W.H., MARTELLI, S., PARADZIEJ-LUKOWICZ, J. & KONOPA, J. (1990a). 5-[(Aminoalkyl) amino]imidazo[4,5,1-de]acridin-6-one as a novel class of antineoplastic agents. Synthesis and biological activity. Journal of Medicinal Chemistry, 33, 49.
6. CHOLODY, W.M., MARTELLI, S. & KONOPA, J. (1990b). 8-Substituted 5-[(aminoalkyl)amino]-6H-n-triazolo[4,5,1-de]acridin-6-ones as potential antineoplastic agents. Synthesis and biological activity. Journal of Medicinal Chemistry, 33, 2852.
7. 1H NMR characterization of substituted 1-amino-9-imino-4-nitro-9,10-dihydroacridines as potential antitumor agents. Journal of Heterocyclic Chemistry, 28, 209.
8. CHOLODY, W.M., MARTELLI, S. & KONOPA, J. (1992). Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against marine leukemias. Journal of Medicinal Chemistry, 35, 378.
9. DENNY, W.A., BAGULEY, B.C., CAIN, B.F. & WARING, M.J. (1983). Antitumour acridines. In Molecular Aspects of Anti-Cancer Drug Action. Neidle, S. & Waring, M.J. (eds), p. 1. Macmillan Press: London.
10. JONES, J.B., DAVEY, C.L., JENKINS, T.C., KAMAL, A., KNEALE, G.G., NEIDLE, S., WEBSTER, G.D. & THURSTON, D.E. (1990). The non-covalent interaction of pyrrolo[2,1-c][1,4]benzodiazepine-5,11-diones with DNA. Anti-Cancer Drug Design, 5, 249.
11. LE PECQ, J.B. & PAOLETTI, C. (1967). A fluorescent complex between ethidium bromide and nucleic acids. Journal of Molecular Biology, 27, 87.
12. MCCONNAUGHIE, A.W. & JENKINS, T.C. (1995). Novel acridine-triazenes as prototype combilexins: synthesis, DNA binding, and biological activity. Journal of Medicinal Chemistry, 38, 3488.
13. MORGAN, A.R., LEE, J.S., PULLEYBLANK, D.E., MURRAY, N.L. & EVANS, D.H. (1979). Review: ethidium fluorescence assays. Part 1. Physicochemical studies. Nucleic Acids Research, 7, 547.
14. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. Journal of Immunological Methods, 65, 55.
15. RUBEN, R.L. & NEUBAUER, R.H. (1987). Semiautomated colorimetric assay for in vitro screening of anticancer compounds. Cancer Treatment Reports, 71, 1141.
16. SUGAYA, T., MIMURA, Y., SHIDA, Y., OSAWA, Y., MATSUKUMA, I., AKINAGA, S. & MORIMOTO, M. (1990). Pyrazoloacridone derivatives as neoplasm inhibitors. European Patent Application EP 347,749, 1989; Chemical Abstracts, 112, 216924h.